secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2024-10-23T23:59:59+00:00
Accession:  0001493152-24-042202
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health gets $10M ARPA-H award for endometriosis blood test
-------------------------------------------------------------------------

- Selected by ARPA-H for $10 million in milestone-based funding over two years to develop EndoMDx blood test for endometriosis.
- EndoMDx is a multi-marker miRNA blood test intended to aid in detection, currently requiring laparoscopic surgery for diagnosis.
- Over 1,700 submissions vied for funding; Aspira will collaborate with ARPA-H Program Manager and Investor Catalyst Hub.
- Virtual Investor Day scheduled for October 29, 2024, at 3:00 pm ET to discuss ARPA-H award and pipeline update.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000149315224042202/0001493152-24-042202-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000149315224042202/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042202

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer